Back to Search
VERONICA SANTINI, M.D., M.A.
M.D., M.A.
Neurology Physician
NPI: 1508097742IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
241553(MA)
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
70185(CT)241553(MA)131510(CA)
CMS Specialties
PrimaryNEUROLOGY
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2009
Research & Publications (20)
Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury.
PMID 19535999·J Neuropathol Exp Neurol·2009
5-case
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
PMID 19230772·Lancet Oncol·2009
3-trial
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes.
PMID 19638460·Clin Cancer Res·2009
3-trial
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia.
PMID 18166784·Haematologica·2008
8-other
Treatment options in myelodysplastic syndromes: a new frontier.
PMID 18606581·J Chemother·2008
6-review
The addition of liposomal doxorubicin to bortezomib, thalidomide and dexamethasone significantly improves clinical outcome of advanced multiple myeloma.
PMID 18410447·Br J Haematol·2008
2-rct
Clock drawing performance in cognitively normal elderly.
PMID 18243644·Arch Clin Neuropsychol·2008
8-other
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells.
PMID 17891169·Oncogene·2008
8-other
Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
PMID 17504226·Curr Drug Metab·2007
6-review
QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA.
PMID 17324562·Nutr Metab Cardiovasc Dis·2007
8-other
A selective activity of DNMTi decitabine on AML1ETO positive cells?
PMID 17240447·Leuk Res·2007
6-review
Comparative proteomic analysis of chronic myelogenous leukemia cells: inside the mechanism of imatinib resistance.
PMID 17203980·J Proteome Res·2007
8-other
Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance.
PMID 18056850·Blood·2007
5-case
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells.
PMID 17054427·Br J Haematol·2006
8-other
Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
PMID 16228241·Ann Hematol·2005
8-other
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?
PMID 15359633·Leuk Lymphoma·2004
8-other
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.
PMID 15109536·Leuk Res·2004
8-other
Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
PMID 14695213·Cancer Res·2003
8-other
Dependence of leukemic cell autofluorescence patterns on the degree of differentiation.
PMID 14606752·Photochem Photobiol Sci·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 HOWARD AVE, YALE VASCULAR NEUROLOGY
NEW HAVEN, CT 06519 - Phone
- (203) 785-4085
Quick Facts
- NPI
- 1508097742
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile